Global Short-acting Insulin Market Research Report 2026

1 Short-acting Insulin Market Overview
1.1 Product Definition
1.2 Short-acting Insulin by Type
1.2.1 Global Short-acting Insulin Market Value by Type: 2025 vs 2032
1.2.2 Regular Insulin
1.2.3 Biosynthetic Human Insulin
1.2.4 Recombinant Human Insulin
1.2.5 Other
1.3 Short-acting Insulin by Application
1.3.1 Global Short-acting Insulin Market Value by Application: 2025 vs 2032
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.3.4 Gestational Diabetes
1.3.5 Complications of Diabetes
1.3.6 Other
1.4 Global Short-acting Insulin Market Size Estimates and Forecasts
1.4.1 Global Short-acting Insulin Revenue 2021–2032
1.4.2 Global Short-acting Insulin Sales 2021–2032
1.4.3 Global Short-acting Insulin Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Short-acting Insulin Market Competition by Manufacturers
2.1 Global Short-acting Insulin Sales Market Share by Manufacturers (2021–2026)
2.2 Global Short-acting Insulin Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Short-acting Insulin Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Short-acting Insulin, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Short-acting Insulin, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Short-acting Insulin, Product Types and Applications
2.7 Global Key Manufacturers of Short-acting Insulin, Date of Entry into the Industry
2.8 Global Short-acting Insulin Market Competitive Situation and Trends
2.8.1 Global Short-acting Insulin Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Short-acting Insulin Players Market Share by Revenue
2.8.3 Global Short-acting Insulin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Short-acting Insulin Market Scenario by Region
3.1 Global Short-acting Insulin Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Short-acting Insulin Sales by Region: 2021–2032
3.2.1 Global Short-acting Insulin Sales by Region: 2021–2026
3.2.2 Global Short-acting Insulin Sales by Region: 2027–2032
3.3 Global Short-acting Insulin Revenue by Region: 2021–2032
3.3.1 Global Short-acting Insulin Revenue by Region: 2021–2026
3.3.2 Global Short-acting Insulin Revenue by Region: 2027–2032
3.4 North America Short-acting Insulin Market Facts & Figures by Country
3.4.1 North America Short-acting Insulin Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Short-acting Insulin Sales by Country (2021–2032)
3.4.3 North America Short-acting Insulin Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Short-acting Insulin Market Facts & Figures by Country
3.5.1 Europe Short-acting Insulin Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Short-acting Insulin Sales by Country (2021–2032)
3.5.3 Europe Short-acting Insulin Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Short-acting Insulin Market Facts & Figures by Region
3.6.1 Asia Pacific Short-acting Insulin Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Short-acting Insulin Sales by Region (2021–2032)
3.6.3 Asia Pacific Short-acting Insulin Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Short-acting Insulin Market Facts & Figures by Country
3.7.1 Latin America Short-acting Insulin Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Short-acting Insulin Sales by Country (2021–2032)
3.7.3 Latin America Short-acting Insulin Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Short-acting Insulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Short-acting Insulin Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Short-acting Insulin Sales by Country (2021–2032)
3.8.3 Middle East and Africa Short-acting Insulin Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Short-acting Insulin Sales by Type (2021–2032)
4.1.1 Global Short-acting Insulin Sales by Type (2021–2026)
4.1.2 Global Short-acting Insulin Sales by Type (2027–2032)
4.1.3 Global Short-acting Insulin Sales Market Share by Type (2021–2032)
4.2 Global Short-acting Insulin Revenue by Type (2021–2032)
4.2.1 Global Short-acting Insulin Revenue by Type (2021–2026)
4.2.2 Global Short-acting Insulin Revenue by Type (2027–2032)
4.2.3 Global Short-acting Insulin Revenue Market Share by Type (2021–2032)
4.3 Global Short-acting Insulin Price by Type (2021–2032)
5 Segment by Application
5.1 Global Short-acting Insulin Sales by Application (2021–2032)
5.1.1 Global Short-acting Insulin Sales by Application (2021–2026)
5.1.2 Global Short-acting Insulin Sales by Application (2027–2032)
5.1.3 Global Short-acting Insulin Sales Market Share by Application (2021–2032)
5.2 Global Short-acting Insulin Revenue by Application (2021–2032)
5.2.1 Global Short-acting Insulin Revenue by Application (2021–2026)
5.2.2 Global Short-acting Insulin Revenue by Application (2027–2032)
5.2.3 Global Short-acting Insulin Revenue Market Share by Application (2021–2032)
5.3 Global Short-acting Insulin Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Company Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Short-acting Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Eli Lilly Short-acting Insulin Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Company Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Short-acting Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Novo Nordisk Short-acting Insulin Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Biocon Biologics
6.3.1 Biocon Biologics Company Information
6.3.2 Biocon Biologics Description and Business Overview
6.3.3 Biocon Biologics Short-acting Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Biocon Biologics Short-acting Insulin Product Portfolio
6.3.5 Biocon Biologics Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Company Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Short-acting Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sanofi Short-acting Insulin Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Wockhardt
6.5.1 Wockhardt Company Information
6.5.2 Wockhardt Description and Business Overview
6.5.3 Wockhardt Short-acting Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Wockhardt Short-acting Insulin Product Portfolio
6.5.5 Wockhardt Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Company Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Short-acting Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Bayer Short-acting Insulin Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Short-acting Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Pfizer Short-acting Insulin Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 BASF
6.8.1 BASF Company Information
6.8.2 BASF Description and Business Overview
6.8.3 BASF Short-acting Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BASF Short-acting Insulin Product Portfolio
6.8.5 BASF Recent Developments/Updates
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Company Information
6.9.2 Abbott Laboratories Description and Business Overview
6.9.3 Abbott Laboratories Short-acting Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Abbott Laboratories Short-acting Insulin Product Portfolio
6.9.5 Abbott Laboratories Recent Developments/Updates
6.10 Tonghua Dongbao Pharmaceutical
6.10.1 Tonghua Dongbao Pharmaceutical Company Information
6.10.2 Tonghua Dongbao Pharmaceutical Description and Business Overview
6.10.3 Tonghua Dongbao Pharmaceutical Short-acting Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Tonghua Dongbao Pharmaceutical Short-acting Insulin Product Portfolio
6.10.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
6.11 Zhuhai United Pharmaceutical
6.11.1 Zhuhai United Pharmaceutical Company Information
6.11.2 Zhuhai United Pharmaceutical Description and Business Overview
6.11.3 Zhuhai United Pharmaceutical Short-acting Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Zhuhai United Pharmaceutical Short-acting Insulin Product Portfolio
6.11.5 Zhuhai United Pharmaceutical Recent Developments/Updates
6.12 Sinovac Biotech
6.12.1 Sinovac Biotech Company Information
6.12.2 Sinovac Biotech Description and Business Overview
6.12.3 Sinovac Biotech Short-acting Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sinovac Biotech Short-acting Insulin Product Portfolio
6.12.5 Sinovac Biotech Recent Developments/Updates
6.13 Wanbang Biopharmaceuticals
6.13.1 Wanbang Biopharmaceuticals Company Information
6.13.2 Wanbang Biopharmaceuticals Description and Business Overview
6.13.3 Wanbang Biopharmaceuticals Short-acting Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Wanbang Biopharmaceuticals Short-acting Insulin Product Portfolio
6.13.5 Wanbang Biopharmaceuticals Recent Developments/Updates
6.14 HTBT
6.14.1 HTBT Company Information
6.14.2 HTBT Description and Business Overview
6.14.3 HTBT Short-acting Insulin Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 HTBT Short-acting Insulin Product Portfolio
6.14.5 HTBT Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Short-acting Insulin Industry Chain Analysis
7.2 Short-acting Insulin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Short-acting Insulin Production Mode & Process Analysis
7.4 Short-acting Insulin Sales and Marketing
7.4.1 Short-acting Insulin Sales Channels
7.4.2 Short-acting Insulin Distributors
7.5 Short-acting Insulin Customer Analysis
8 Short-acting Insulin Market Dynamics
8.1 Short-acting Insulin Industry Trends
8.2 Short-acting Insulin Market Drivers
8.3 Short-acting Insulin Market Challenges
8.4 Short-acting Insulin Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Short-acting Insulin Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Short-acting Insulin Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Short-acting Insulin Market Competitive Situation by Manufacturers in 2025
Table 4. Global Short-acting Insulin Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Short-acting Insulin Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Short-acting Insulin Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Short-acting Insulin Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Short-acting Insulin Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Short-acting Insulin, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Short-acting Insulin, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Short-acting Insulin, Product Types and Applications
Table 12. Global Key Manufacturers of Short-acting Insulin, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Short-acting Insulin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Short-acting Insulin Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Short-acting Insulin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Short-acting Insulin Sales by Region (K Units), 2021–2026
Table 18. Global Short-acting Insulin Sales Market Share by Region (2021–2026)
Table 19. Global Short-acting Insulin Sales by Region (K Units), 2027–2032
Table 20. Global Short-acting Insulin Sales Market Share by Region (2027–2032)
Table 21. Global Short-acting Insulin Revenue by Region (US$ Million), 2021–2026
Table 22. Global Short-acting Insulin Revenue Market Share by Region (2021–2026)
Table 23. Global Short-acting Insulin Revenue by Region (US$ Million), 2027–2032
Table 24. Global Short-acting Insulin Revenue Market Share by Region (2027–2032)
Table 25. North America Short-acting Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Short-acting Insulin Sales by Country (K Units), 2021–2026
Table 27. North America Short-acting Insulin Sales by Country (K Units), 2027–2032
Table 28. North America Short-acting Insulin Revenue by Country (US$ Million), 2021–2026
Table 29. North America Short-acting Insulin Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Short-acting Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Short-acting Insulin Sales by Country (K Units), 2021–2026
Table 32. Europe Short-acting Insulin Sales by Country (K Units), 2027–2032
Table 33. Europe Short-acting Insulin Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Short-acting Insulin Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Short-acting Insulin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Short-acting Insulin Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Short-acting Insulin Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Short-acting Insulin Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Short-acting Insulin Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Short-acting Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Short-acting Insulin Sales by Country (K Units), 2021–2026
Table 42. Latin America Short-acting Insulin Sales by Country (K Units), 2027–2032
Table 43. Latin America Short-acting Insulin Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Short-acting Insulin Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Short-acting Insulin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Short-acting Insulin Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Short-acting Insulin Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Short-acting Insulin Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Short-acting Insulin Revenue by Country (US$ Million), 2027–2032
Table 50. Global Short-acting Insulin Sales (K Units) by Type (2021–2026)
Table 51. Global Short-acting Insulin Sales (K Units) by Type (2027–2032)
Table 52. Global Short-acting Insulin Sales Market Share by Type (2021–2026)
Table 53. Global Short-acting Insulin Sales Market Share by Type (2027–2032)
Table 54. Global Short-acting Insulin Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Short-acting Insulin Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Short-acting Insulin Revenue Market Share by Type (2021–2026)
Table 57. Global Short-acting Insulin Revenue Market Share by Type (2027–2032)
Table 58. Global Short-acting Insulin Price (US$/Unit) by Type (2021–2026)
Table 59. Global Short-acting Insulin Price (US$/Unit) by Type (2027–2032)
Table 60. Global Short-acting Insulin Sales (K Units) by Application (2021–2026)
Table 61. Global Short-acting Insulin Sales (K Units) by Application (2027–2032)
Table 62. Global Short-acting Insulin Sales Market Share by Application (2021–2026)
Table 63. Global Short-acting Insulin Sales Market Share by Application (2027–2032)
Table 64. Global Short-acting Insulin Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Short-acting Insulin Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Short-acting Insulin Revenue Market Share by Application (2021–2026)
Table 67. Global Short-acting Insulin Revenue Market Share by Application (2027–2032)
Table 68. Global Short-acting Insulin Price (US$/Unit) by Application (2021–2026)
Table 69. Global Short-acting Insulin Price (US$/Unit) by Application (2027–2032)
Table 70. Eli Lilly Company Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly Short-acting Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Eli Lilly Short-acting Insulin Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. Novo Nordisk Company Information
Table 76. Novo Nordisk Description and Business Overview
Table 77. Novo Nordisk Short-acting Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Novo Nordisk Short-acting Insulin Product
Table 79. Novo Nordisk Recent Developments/Updates
Table 80. Biocon Biologics Company Information
Table 81. Biocon Biologics Description and Business Overview
Table 82. Biocon Biologics Short-acting Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Biocon Biologics Short-acting Insulin Product
Table 84. Biocon Biologics Recent Developments/Updates
Table 85. Sanofi Company Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Short-acting Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sanofi Short-acting Insulin Product
Table 89. Sanofi Recent Developments/Updates
Table 90. Wockhardt Company Information
Table 91. Wockhardt Description and Business Overview
Table 92. Wockhardt Short-acting Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Wockhardt Short-acting Insulin Product
Table 94. Wockhardt Recent Developments/Updates
Table 95. Bayer Company Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer Short-acting Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Bayer Short-acting Insulin Product
Table 99. Bayer Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Short-acting Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Pfizer Short-acting Insulin Product
Table 104. Pfizer Recent Developments/Updates
Table 105. BASF Company Information
Table 106. BASF Description and Business Overview
Table 107. BASF Short-acting Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. BASF Short-acting Insulin Product
Table 109. BASF Recent Developments/Updates
Table 110. Abbott Laboratories Company Information
Table 111. Abbott Laboratories Description and Business Overview
Table 112. Abbott Laboratories Short-acting Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Abbott Laboratories Short-acting Insulin Product
Table 114. Abbott Laboratories Recent Developments/Updates
Table 115. Tonghua Dongbao Pharmaceutical Company Information
Table 116. Tonghua Dongbao Pharmaceutical Description and Business Overview
Table 117. Tonghua Dongbao Pharmaceutical Short-acting Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Tonghua Dongbao Pharmaceutical Short-acting Insulin Product
Table 119. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 120. Zhuhai United Pharmaceutical Company Information
Table 121. Zhuhai United Pharmaceutical Description and Business Overview
Table 122. Zhuhai United Pharmaceutical Short-acting Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Zhuhai United Pharmaceutical Short-acting Insulin Product
Table 124. Zhuhai United Pharmaceutical Recent Developments/Updates
Table 125. Sinovac Biotech Company Information
Table 126. Sinovac Biotech Description and Business Overview
Table 127. Sinovac Biotech Short-acting Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Sinovac Biotech Short-acting Insulin Product
Table 129. Sinovac Biotech Recent Developments/Updates
Table 130. Wanbang Biopharmaceuticals Company Information
Table 131. Wanbang Biopharmaceuticals Description and Business Overview
Table 132. Wanbang Biopharmaceuticals Short-acting Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Wanbang Biopharmaceuticals Short-acting Insulin Product
Table 134. Wanbang Biopharmaceuticals Recent Developments/Updates
Table 135. HTBT Company Information
Table 136. HTBT Description and Business Overview
Table 137. HTBT Short-acting Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. HTBT Short-acting Insulin Product
Table 139. HTBT Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Short-acting Insulin Distributors List
Table 143. Short-acting Insulin Customers List
Table 144. Short-acting Insulin Market Trends
Table 145. Short-acting Insulin Market Drivers
Table 146. Short-acting Insulin Market Challenges
Table 147. Short-acting Insulin Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report


List of Figures
Figure 1. Product Picture of Short-acting Insulin
Figure 2. Global Short-acting Insulin Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Short-acting Insulin Market Share by Type: 2025 & 2032
Figure 4. Regular Insulin Product Picture
Figure 5. Biosynthetic Human Insulin Product Picture
Figure 6. Recombinant Human Insulin Product Picture
Figure 7. Other Product Picture
Figure 8. Global Short-acting Insulin Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Short-acting Insulin Market Share by Application: 2025 & 2032
Figure 10. Type 1 Diabetes
Figure 11. Type 2 Diabetes
Figure 12. Gestational Diabetes
Figure 13. Complications of Diabetes
Figure 14. Other
Figure 15. Global Short-acting Insulin Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Short-acting Insulin Market Size (US$ Million), 2021–2032
Figure 17. Global Short-acting Insulin Sales (K Units), 2021–2032
Figure 18. Global Short-acting Insulin Average Price (US$/Unit), 2021–2032
Figure 19. Short-acting Insulin Report Years Considered
Figure 20. Short-acting Insulin Sales Share by Manufacturers in 2025
Figure 21. Global Short-acting Insulin Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global Short-acting Insulin Players: Market Share by Revenue in Short-acting Insulin in 2025
Figure 23. Short-acting Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global Short-acting Insulin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America Short-acting Insulin Sales Market Share by Country (2021–2032)
Figure 26. North America Short-acting Insulin Revenue Market Share by Country (2021–2032)
Figure 27. United States Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe Short-acting Insulin Sales Market Share by Country (2021–2032)
Figure 30. Europe Short-acting Insulin Revenue Market Share by Country (2021–2032)
Figure 31. Germany Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific Short-acting Insulin Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific Short-acting Insulin Revenue Market Share by Region (2021–2032)
Figure 38. China Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. China Taiwan Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Southeast Asia Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Short-acting Insulin Sales Market Share by Country (2021–2032)
Figure 46. Latin America Short-acting Insulin Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Colombia Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa Short-acting Insulin Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa Short-acting Insulin Revenue Market Share by Country (2021–2032)
Figure 53. Turkey Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. UAE Short-acting Insulin Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of Short-acting Insulin by Type (2021–2032)
Figure 57. Global Revenue Market Share of Short-acting Insulin by Type (2021–2032)
Figure 58. Global Short-acting Insulin Price (US$/Unit) by Type (2021–2032)
Figure 59. Global Sales Market Share of Short-acting Insulin by Application (2021–2032)
Figure 60. Global Revenue Market Share of Short-acting Insulin by Application (2021–2032)
Figure 61. Global Short-acting Insulin Price (US$/Unit) by Application (2021–2032)
Figure 62. Short-acting Insulin Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit